How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats

Jian Shen, Jianjun Ma, Cassandra A Lee, Beth P. Smith, Thomas L. Smith, Kim H. Tan, L. Andrew Koman

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Botulinum toxin A (BoNT-A) is a potent biological toxin widely used for the management of skeletal muscle spasticity or dynamic joint contracture. Intramuscular injection of BoNT-A causes muscle denervation, paresis, and atrophy. This clinical effect of botulinum toxin A lasts 3 to 6 months, and injected muscle eventually regains muscle mass and recovers muscle function. The goal of the present study was to characterize the molecular and cellular mechanisms leading to neuromuscular junction (NMJ) regeneration and skeletal muscle functional recovery after BoNT-A injection. Fifty-six 1-month-old Sprague-Dawley rats were used. Botulinum toxin A was injected into the left gastrocnemius muscle at a dosage of 6 units/kg body weight. An equivalent volume of saline was injected into the right gastrocnemius muscle to serve as control. The gastrocnemius muscle samples were harvested from both hind limbs at 3 days, 7 days, 15 days, 30 days, 60 days, 90 days, 180 days, and 360 days after administration of toxin. In addition, the gastrocnemius muscles from 1-month-old rats with no injections were harvested to serve as uninjected control group. Muscle samples were processed and mRNA was extracted. Real-time polymerase chain reaction (PCR) and gene microarray technology were used to identify key molecules involved in NMJ stabilization and muscle functional recovery. More than 28,000 rat genes were analyzed and approximately 9000 genes are expressed in the rat gastrocnemius muscle. Seven days following BoNT-A injection, 105 genes were upregulated and 59 genes were downregulated. Key molecules involved in neuromuscular junction (NMJ) stabilization and muscle functional recovery were identified and their time course of gene expression following BoNT-A injection were characterized. This animal study demonstrates that following intramuscular injection of BoNT-A, there is a sequence of cellular events that eventually leads to NMJ stabilization, remodeling, and myogenesis and muscle functional recovery. This recovery process is divided into two stages (aneural and neural) and that the IGF-1 signaling pathway play a central role in the process.

Original languageEnglish (US)
Pages (from-to)1128-1135
Number of pages8
JournalJournal of Orthopaedic Research
Volume24
Issue number5
DOIs
StatePublished - May 2006
Externally publishedYes

Fingerprint

Type A Botulinum Toxins
Muscular Atrophy
Intramuscular Injections
Paresis
Skeletal Muscle
Neuromuscular Junction
Muscles
Injections
Genes
Biological Toxins
Muscle Denervation
Muscle Spasticity
Muscle Development
Contracture
Insulin-Like Growth Factor I
Sprague Dawley Rats
Real-Time Polymerase Chain Reaction
Regeneration
Down-Regulation
Extremities

Keywords

  • Botulinum toxin
  • Gene
  • Microarray
  • Neuromuscular junction
  • Rats

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A : Study in juvenile rats. / Shen, Jian; Ma, Jianjun; Lee, Cassandra A; Smith, Beth P.; Smith, Thomas L.; Tan, Kim H.; Koman, L. Andrew.

In: Journal of Orthopaedic Research, Vol. 24, No. 5, 05.2006, p. 1128-1135.

Research output: Contribution to journalArticle

Shen, Jian ; Ma, Jianjun ; Lee, Cassandra A ; Smith, Beth P. ; Smith, Thomas L. ; Tan, Kim H. ; Koman, L. Andrew. / How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A : Study in juvenile rats. In: Journal of Orthopaedic Research. 2006 ; Vol. 24, No. 5. pp. 1128-1135.
@article{aa704cff292e42c4843486ece108ba72,
title = "How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats",
abstract = "Botulinum toxin A (BoNT-A) is a potent biological toxin widely used for the management of skeletal muscle spasticity or dynamic joint contracture. Intramuscular injection of BoNT-A causes muscle denervation, paresis, and atrophy. This clinical effect of botulinum toxin A lasts 3 to 6 months, and injected muscle eventually regains muscle mass and recovers muscle function. The goal of the present study was to characterize the molecular and cellular mechanisms leading to neuromuscular junction (NMJ) regeneration and skeletal muscle functional recovery after BoNT-A injection. Fifty-six 1-month-old Sprague-Dawley rats were used. Botulinum toxin A was injected into the left gastrocnemius muscle at a dosage of 6 units/kg body weight. An equivalent volume of saline was injected into the right gastrocnemius muscle to serve as control. The gastrocnemius muscle samples were harvested from both hind limbs at 3 days, 7 days, 15 days, 30 days, 60 days, 90 days, 180 days, and 360 days after administration of toxin. In addition, the gastrocnemius muscles from 1-month-old rats with no injections were harvested to serve as uninjected control group. Muscle samples were processed and mRNA was extracted. Real-time polymerase chain reaction (PCR) and gene microarray technology were used to identify key molecules involved in NMJ stabilization and muscle functional recovery. More than 28,000 rat genes were analyzed and approximately 9000 genes are expressed in the rat gastrocnemius muscle. Seven days following BoNT-A injection, 105 genes were upregulated and 59 genes were downregulated. Key molecules involved in neuromuscular junction (NMJ) stabilization and muscle functional recovery were identified and their time course of gene expression following BoNT-A injection were characterized. This animal study demonstrates that following intramuscular injection of BoNT-A, there is a sequence of cellular events that eventually leads to NMJ stabilization, remodeling, and myogenesis and muscle functional recovery. This recovery process is divided into two stages (aneural and neural) and that the IGF-1 signaling pathway play a central role in the process.",
keywords = "Botulinum toxin, Gene, Microarray, Neuromuscular junction, Rats",
author = "Jian Shen and Jianjun Ma and Lee, {Cassandra A} and Smith, {Beth P.} and Smith, {Thomas L.} and Tan, {Kim H.} and Koman, {L. Andrew}",
year = "2006",
month = "5",
doi = "10.1002/jor.20131",
language = "English (US)",
volume = "24",
pages = "1128--1135",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A

T2 - Study in juvenile rats

AU - Shen, Jian

AU - Ma, Jianjun

AU - Lee, Cassandra A

AU - Smith, Beth P.

AU - Smith, Thomas L.

AU - Tan, Kim H.

AU - Koman, L. Andrew

PY - 2006/5

Y1 - 2006/5

N2 - Botulinum toxin A (BoNT-A) is a potent biological toxin widely used for the management of skeletal muscle spasticity or dynamic joint contracture. Intramuscular injection of BoNT-A causes muscle denervation, paresis, and atrophy. This clinical effect of botulinum toxin A lasts 3 to 6 months, and injected muscle eventually regains muscle mass and recovers muscle function. The goal of the present study was to characterize the molecular and cellular mechanisms leading to neuromuscular junction (NMJ) regeneration and skeletal muscle functional recovery after BoNT-A injection. Fifty-six 1-month-old Sprague-Dawley rats were used. Botulinum toxin A was injected into the left gastrocnemius muscle at a dosage of 6 units/kg body weight. An equivalent volume of saline was injected into the right gastrocnemius muscle to serve as control. The gastrocnemius muscle samples were harvested from both hind limbs at 3 days, 7 days, 15 days, 30 days, 60 days, 90 days, 180 days, and 360 days after administration of toxin. In addition, the gastrocnemius muscles from 1-month-old rats with no injections were harvested to serve as uninjected control group. Muscle samples were processed and mRNA was extracted. Real-time polymerase chain reaction (PCR) and gene microarray technology were used to identify key molecules involved in NMJ stabilization and muscle functional recovery. More than 28,000 rat genes were analyzed and approximately 9000 genes are expressed in the rat gastrocnemius muscle. Seven days following BoNT-A injection, 105 genes were upregulated and 59 genes were downregulated. Key molecules involved in neuromuscular junction (NMJ) stabilization and muscle functional recovery were identified and their time course of gene expression following BoNT-A injection were characterized. This animal study demonstrates that following intramuscular injection of BoNT-A, there is a sequence of cellular events that eventually leads to NMJ stabilization, remodeling, and myogenesis and muscle functional recovery. This recovery process is divided into two stages (aneural and neural) and that the IGF-1 signaling pathway play a central role in the process.

AB - Botulinum toxin A (BoNT-A) is a potent biological toxin widely used for the management of skeletal muscle spasticity or dynamic joint contracture. Intramuscular injection of BoNT-A causes muscle denervation, paresis, and atrophy. This clinical effect of botulinum toxin A lasts 3 to 6 months, and injected muscle eventually regains muscle mass and recovers muscle function. The goal of the present study was to characterize the molecular and cellular mechanisms leading to neuromuscular junction (NMJ) regeneration and skeletal muscle functional recovery after BoNT-A injection. Fifty-six 1-month-old Sprague-Dawley rats were used. Botulinum toxin A was injected into the left gastrocnemius muscle at a dosage of 6 units/kg body weight. An equivalent volume of saline was injected into the right gastrocnemius muscle to serve as control. The gastrocnemius muscle samples were harvested from both hind limbs at 3 days, 7 days, 15 days, 30 days, 60 days, 90 days, 180 days, and 360 days after administration of toxin. In addition, the gastrocnemius muscles from 1-month-old rats with no injections were harvested to serve as uninjected control group. Muscle samples were processed and mRNA was extracted. Real-time polymerase chain reaction (PCR) and gene microarray technology were used to identify key molecules involved in NMJ stabilization and muscle functional recovery. More than 28,000 rat genes were analyzed and approximately 9000 genes are expressed in the rat gastrocnemius muscle. Seven days following BoNT-A injection, 105 genes were upregulated and 59 genes were downregulated. Key molecules involved in neuromuscular junction (NMJ) stabilization and muscle functional recovery were identified and their time course of gene expression following BoNT-A injection were characterized. This animal study demonstrates that following intramuscular injection of BoNT-A, there is a sequence of cellular events that eventually leads to NMJ stabilization, remodeling, and myogenesis and muscle functional recovery. This recovery process is divided into two stages (aneural and neural) and that the IGF-1 signaling pathway play a central role in the process.

KW - Botulinum toxin

KW - Gene

KW - Microarray

KW - Neuromuscular junction

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=33744484015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744484015&partnerID=8YFLogxK

U2 - 10.1002/jor.20131

DO - 10.1002/jor.20131

M3 - Article

C2 - 16602109

AN - SCOPUS:33744484015

VL - 24

SP - 1128

EP - 1135

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 5

ER -